Senate health committee to vote on rare subpoenas for J&J and Merck CEOs over drug pricing testimony

Sen­ate Health, Ed­u­ca­tion, La­bor and Pen­sions Com­mit­tee Chair Bernie Sanders (I-VT) said Thurs­day that he will hold a vote on whether to is­sue sub­poe­nas for John­son & John­son CEO Joaquin Du­a­to and Mer­ck CEO Robert Davis, both of whom are re­fus­ing to pro­vide tes­ti­mo­ny about “why their com­pa­nies charge sub­stan­tial­ly high­er prices for med­i­cine in the U.S. com­pared to oth­er coun­tries,” Sanders said in a state­ment.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.